Literature DB >> 26770636

Study on like-stem characteristics of tumor sphere cells in human gastric cancer line HGC-27.

Wei-Hong Shi1, Cong Li1, Jin-Jing Liu1, Zheng-Li Wei1, Jia Liu1, Wan-Wei Dong1, Wei Yang1, Wei Wang1, Zhi-Hong Zheng1.   

Abstract

Stem-like cancer cells are called cancer stem cells (CSCs) or tumor stem cells (TSCs). Methods for sorting CSCs are mainly based on the marker (CD133+/CD44+) or side population cells. However, CD133+/CD44+ cells or side population cells are very rare or even undetectable. In the present study, the tumor sphere of human gastric cancer (HGC) cell line HGC-27 was used for CSCs enrichment, and stem-like characteristics were verified by Hoechst 33342 staining technology, cell growth rate assays, sphere differentiation assay, clone formation, chemotherapy resistance study and tumor formation in an animal model. Our results demonstrated that the tumor sphere cells of HGC-27 cell line could be used to enrich CSCs, which may contribute to human gastric cancer stem cell biology research.

Entities:  

Keywords:  Cancer stem cells; gastric cancer; stem-like characteristics; tumor sphere

Year:  2015        PMID: 26770636      PMCID: PMC4694536     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  32 in total

1.  Establishment of clonal colony-forming assay system for pancreatic stem/progenitor cells.

Authors:  Atsushi Suzuki; Kazunobu Oyama; Katashi Fukao; Hiromitsu Nakauchi; Hideki Taniguchi
Journal:  Cell Transplant       Date:  2002       Impact factor: 4.064

Review 2.  Applying the principles of stem-cell biology to cancer.

Authors:  Ricardo Pardal; Michael F Clarke; Sean J Morrison
Journal:  Nat Rev Cancer       Date:  2003-12       Impact factor: 60.716

3.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

4.  Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues.

Authors:  Patricia A Fetsch; Andrea Abati; Thomas Litman; Kuniaki Morisaki; Yasumasa Honjo; Khush Mittal; Susan E Bates
Journal:  Cancer Lett       Date:  2005-06-28       Impact factor: 8.679

Review 5.  Cancer stem cells: lessons from leukemia.

Authors:  Jean C Y Wang; John E Dick
Journal:  Trends Cell Biol       Date:  2005-09       Impact factor: 20.808

6.  Stem-like cells in bone sarcomas: implications for tumorigenesis.

Authors:  C Parker Gibbs; Valery G Kukekov; John D Reith; Olga Tchigrinova; Oleg N Suslov; Edward W Scott; Steven C Ghivizzani; Tatyana N Ignatova; Dennis A Steindler
Journal:  Neoplasia       Date:  2005-11       Impact factor: 5.715

Review 7.  Tumour stem cells and drug resistance.

Authors:  Michael Dean; Tito Fojo; Susan Bates
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

8.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.

Authors:  T Lapidot; C Sirard; J Vormoor; B Murdoch; T Hoang; J Caceres-Cortes; M Minden; B Paterson; M A Caligiuri; J E Dick
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

Review 9.  Gastric cancer stem cells.

Authors:  Shigeo Takaishi; Tomoyuki Okumura; Timothy C Wang
Journal:  J Clin Oncol       Date:  2008-06-10       Impact factor: 44.544

10.  Identification and expansion of the tumorigenic lung cancer stem cell population.

Authors:  A Eramo; F Lotti; G Sette; E Pilozzi; M Biffoni; A Di Virgilio; C Conticello; L Ruco; C Peschle; R De Maria
Journal:  Cell Death Differ       Date:  2007-11-30       Impact factor: 15.828

View more
  1 in total

1.  NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma.

Authors:  Zhi-Jie Xiao; Jing Liu; Si-Qi Wang; Yun Zhu; Xu-Yuan Gao; Vicky Pui-Chi Tin; Jing Qin; Jun-Wen Wang; Maria Pik Wong
Journal:  Elife       Date:  2017-07-24       Impact factor: 8.140

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.